182 related articles for article (PubMed ID: 23924802)
21. Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries.
Medecigo M; Manoutcharian K; Vasilevko V; Govezensky T; Munguia ME; Becerril B; Luz-Madrigal A; Vaca L; Cribbs DH; Gevorkian G
J Neuroimmunol; 2010 Jun; 223(1-2):104-14. PubMed ID: 20451261
[TBL] [Abstract][Full Text] [Related]
22. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
Jäger M; Plückthun A
FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
[TBL] [Abstract][Full Text] [Related]
23. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide.
Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R
Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180
[TBL] [Abstract][Full Text] [Related]
24. An unusual cysteine V
Attallah C; Aguilar MF; Garay AS; Herrera FE; Etcheverrigaray M; Oggero M; Rodrigues DE
Mol Immunol; 2017 Oct; 90():143-149. PubMed ID: 28755586
[TBL] [Abstract][Full Text] [Related]
25. Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth.
Li SL; Liang SJ; Guo N; Wu AM; Fujita-Yamaguchi Y
Cancer Immunol Immunother; 2000 Jul; 49(4-5):243-52. PubMed ID: 10941907
[TBL] [Abstract][Full Text] [Related]
26. Antibody scFv fragments without disulfide bonds made by molecular evolution.
Proba K; Wörn A; Honegger A; Plückthun A
J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
[TBL] [Abstract][Full Text] [Related]
27. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
Jäger M; Plückthun A
J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
[TBL] [Abstract][Full Text] [Related]
28. Functional Characteristics and Molecular Mechanism of a New scFv Antibody Against Aβ42 Oligomers and Immature Protofibrils.
Zhang Y; Sun Y; Huai Y; Zhang YJ
Mol Neurobiol; 2015 Dec; 52(3):1269-1281. PubMed ID: 25330935
[TBL] [Abstract][Full Text] [Related]
29. Production and characterization of a bacterial single-chain antibody fragment specific to B-cell-activating factor of the TNF family.
Cao P; Tang XM; Guan ZB; Diao ZY; Zhang SQ
Protein Expr Purif; 2005 Oct; 43(2):157-64. PubMed ID: 16023370
[TBL] [Abstract][Full Text] [Related]
30. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
[TBL] [Abstract][Full Text] [Related]
31. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
[TBL] [Abstract][Full Text] [Related]
32. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vlambda6 proteins.
Wall JS; Gupta V; Wilkerson M; Schell M; Loris R; Adams P; Solomon A; Stevens F; Dealwis C
J Mol Recognit; 2004; 17(4):323-31. PubMed ID: 15227639
[TBL] [Abstract][Full Text] [Related]
33. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
Röthlisberger D; Honegger A; Plückthun A
J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
[TBL] [Abstract][Full Text] [Related]
34. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.
Chen Y; Bai Y; Guo X; Wang W; Zheng Q; Wang F; Sun D; Li D; Ren G; Yin J
Biologicals; 2016 Jul; 44(4):271-275. PubMed ID: 27255707
[TBL] [Abstract][Full Text] [Related]
35. Towards a universal disulphide stabilised single chain Fv format: importance of interchain disulphide bond location and vL-vH orientation.
Weatherill EE; Cain KL; Heywood SP; Compson JE; Heads JT; Adams R; Humphreys DP
Protein Eng Des Sel; 2012 Jul; 25(7):321-9. PubMed ID: 22586154
[TBL] [Abstract][Full Text] [Related]
36. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
[TBL] [Abstract][Full Text] [Related]
37. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease.
Giménez-Llort L; Rivera-Hernández G; Marin-Argany M; Sánchez-Quesada JL; Villegas S
MAbs; 2013; 5(5):665-77. PubMed ID: 23884018
[TBL] [Abstract][Full Text] [Related]
38. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.
Wörn A; Plückthun A
FEBS Lett; 1998 May; 427(3):357-61. PubMed ID: 9637257
[TBL] [Abstract][Full Text] [Related]
39. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain.
Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP
Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224
[TBL] [Abstract][Full Text] [Related]
40. Directed evolution of human heavy chain variable domain (VH) using in vivo protein fitness filter.
Kim DS; Song HN; Nam HJ; Kim SG; Park YS; Park JC; Woo EJ; Lim HK
PLoS One; 2014; 9(6):e98178. PubMed ID: 24892548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
